CD4 and multiple sclerosis: Previous studies have shown that the inhibition of CD4+CD25+Foxp3+Tregs result in the functional impairment or decrease in the number of cells in various ADs such as multiple sclerosis (MS) and rheumatoid arthritis (RA) [29, 30].